The DOI matches its Crossref record; 187 of the 187 references it cites were found in a registry or an index.
Polymeric Conjugates for Drug Delivery
Open accessAbstract
The field of polymer therapeutics has evolved over the past decade and has resulted in the development of polymer-drug conjugates with a wide variety of architectures and chemical properties. Whereas traditional non-degradable polymeric carriers such as poly(ethylene glycol) (PEG) and N-(2-hydroxypropyl methacrylamide) (HPMA) copolymers have been translated to use in the clinic, functionalized polymer-drug conjugates are increasingly being utilized to obtain biodegradable, stimuli-sensitive, and targeted systems in an attempt to further enhance localized drug delivery and ease of elimination. In addition, the study of conjugates bearing both therapeutic and diagnostic agents has resulted in multifunctional carriers with the potential to both "see and treat" patients. In this paper, the rational design of polymer-drug conjugates will be discussed followed by a review of different classes of conjugates currently under investigation. The design and chemistry used for the synthesis of various conjugates will be presented with additional comments on their potential applications and current developmental status.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
A New Class of Polymers: Starburst-Dendritic Macromolecules
Tomalia, D. A., Baker, H., Dewald, J., Hall, M., Kallos, G., Martin, S., Roeck, J., Ryder, J., & Smith, P. (1985) · Polymer Journal · doi:10.1295/polymj.17.117 · Cited by 3,904
Fang, J., Nakamura, H., & Maeda, H. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.04.009 · Cited by 3,559
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Knop, K., Hoogenboom, R., Fischer, D., & Schubert, U. S. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200902672 · Cited by 3,533
(1989) · PubMed · Cited by 3,343
Danhier, F., Feron, O., & Préat, V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,800
Targeted drug delivery to tumors: Myths, reality and possibility
Bae, Y. H., & Park, K. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.001 · Cited by 1,935
Dendrimers in biomedical applications—reflections on the field
SVENSON, S., & TOMALIA, D. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.018 · Cited by 1,919
Micellar Nanocarriers: Pharmaceutical Perspectives
Torchilin, V. P. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9132-0 · Cited by 1,910
Exploiting the enhanced permeability and retention effect for tumor targeting
Iyer, A. K., Khaled, G., Fang, J., & Maeda, H. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.07.005 · Cited by 1,846
Structure and design of polymeric surfactant-based drug delivery systems
Torchilin, V. P. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00299-1 · Cited by 1,822
Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications
Esfand, R., & Tomalia, D. A. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(01)01757-3 · Cited by 1,562
Pluronic® block copolymers as novel polymer therapeutics for drug and gene delivery
Kabanov, A. V., Batrakova, E. V., & Alakhov, V. Y. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00009-3 · Cited by 1,474
Solubilizing Excipients in Oral and Injectable Formulations
Strickley, R. G. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016235.32639.23 · Cited by 1,415
Bae, Y., Fukushima, S., Harada, A., & Kataoka, K. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200250653 · Cited by 1,329
Nanostructured functional materials prepared by atom transfer radical polymerization
Matyjaszewski, K., & Tsarevsky, N. V. (2009) · Nature Chemistry · doi:10.1038/nchem.257 · Cited by 1,258
Imaging and drug delivery using theranostic nanoparticles
Janib, S. M., Moses, A. S., & MacKay, J. A. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.08.004 · Cited by 1,248
Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect
Maeda, H., Bharate, G. Y., & Daruwalla, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.11.010 · Cited by 1,168
(1996) · PubMed · Cited by 1,141
Reduction-sensitive polymers and bioconjugates for biomedical applications
Meng, F., Hennink, W. E., & Zhong, Z. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.01.026 · Cited by 1,131
Structure and properties of pharmacologically active polymers
Ringsdorf, H. (1975) · Journal of Polymer Science: Polymer Symposia · doi:10.1002/polc.5070510111 · Cited by 1,094
Bioapplications of RAFT Polymerization
Boyer, C., Bulmus, V., Davis, T. P., Ladmiral, V., Liu, J., & Perrier, S. (2009) · Chemical Reviews · doi:10.1021/cr9001403 · Cited by 1,015
Tumor-Selective Delivery of Macromolecular Drugs via the EPR Effect: Background and Future Prospects
Maeda, H. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100070g · Cited by 998
Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release
Oerlemans, C., Bult, W., Bos, M., Storm, G., Nijsen, J. F. W., & Hennink, W. E. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0233-4 · Cited by 947
Purification of recombinant proteins by fusion with thermally-responsive polypeptides
Meyer, D. E., & Chilkoti, A. (1999) · Nature Biotechnology · doi:10.1038/15100 · Cited by 914
Kukowska-Latallo, J. F., Candido, K. A., Cao, Z., Nigavekar, S. S., Majoros, I. J., Thomas, T. P., Balogh, L. P., Khan, M. K., & Baker, J. R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3921 · Cited by 912
The relevance of tumour pH to the treatment of malignant disease
Wike-Hooley, J. L., Haveman, J., & Reinhold, H. S. (1984) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(84)80077-8 · Cited by 903
Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant
Trainer, P. J., Drake, W. M., Katznelson, L., Freda, P. U., Herman-Bonert, V., van der Lely, A. J., Dimaraki, E. V., Stewart, P. M., Friend, K. E., Vance, M. L., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004203421604 · Cited by 879
Dendritic macromolecules: synthesis of starburst dendrimers
Tomalia, D. A., Baker, H., Dewald, J., Hall, M., Kallos, G., Martin, S., Roeck, J., Ryder, J., & Smith, P. (1986) · Macromolecules · doi:10.1021/ma00163a029 · Cited by 876
Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications
Menjoge, A. R., Kannan, R. M., & Tomalia, D. A. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.01.009 · Cited by 795
Poly(ethylene oxide)-block-poly(l-amino acid) micelles for drug delivery
Lavasanifar, A., Samuel, J., & Kwon, G. S. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00015-7 · Cited by 756
Bae, Y., Nishiyama, N., Fukushima, S., Koyama, H., Yasuhiro, M., & Kataoka, K. (2005) · Bioconjugate Chemistry · doi:10.1021/bc0498166 · Cited by 742
Block copolymer micelles for delivery of gene and related compounds
Kakizawa, Y., & Kataoka, K. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00017-0 · Cited by 738
DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition
Pommier, Y. (2009) · Chemical Reviews · doi:10.1021/cr900097c · Cited by 707
Vasey, P. A., Kaye, S. B., Morrison, R. A., Twelves, C. J., Wilson, P., Duncan, R., Thomson, A. H., Murray, L. S., Hilditch, T. E., Murray, T., et al. (1999) · PubMed · Cited by 689
PEGylation of therapeutic proteins
Jevševar, S., Kunstelj, M., & Porekar, V. G. (2010) · Biotechnology Journal · doi:10.1002/biot.200900218 · Cited by 681
Dendrimers as Carriers for Delivery of Chemotherapeutic Agents
Medina, S. H., & El-Sayed, M. E. H. (2009) · Chemical Reviews · doi:10.1021/cr900174j · Cited by 669
Lee, C. C., Gillies, E. R., Fox, M. E., Guillaudeu, S. J., Fréchet, J. M. J., Dy, E. E., & Szoka, F. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607705103 · Cited by 650
Stimuli-responsive polymers and their applications in drug delivery
Bawa, P., Pillay, V., Choonara, Y. E., & du Toit, L. C. (2009) · Biomedical Materials · doi:10.1088/1748-6041/4/2/022001 · Cited by 641
Bailon, P., Palleroni, A., Schaffer, C. A., Spence, C. L., Fung, W.-J., Porter, J. E., Ehrlich, G. K., Pan, W., Xu, Z.-X., Modi, M. W., et al. (2001) · Bioconjugate Chemistry · doi:10.1021/bc000082g · Cited by 611
PEG Branched Polymer for Functionalization of Nanomaterials with Ultralong Blood Circulation
Prencipe, G., Tabakman, S. M., Welsher, K., Liu, Z., Goodwin, A. P., Zhang, L., Henry, J., & Dai, H. (2009) · Journal of the American Chemical Society · doi:10.1021/ja809086q · Cited by 600
Greish, K. (2007) · Journal of Drug Targeting · doi:10.1080/10611860701539584 · Cited by 600
Multifunctional and stimuli-sensitive pharmaceutical nanocarriers
Torchilin, V. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.026 · Cited by 583
HPMA copolymers: Origins, early developments, present, and future☆
Kopeček, J., & Kopečková, P. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.10.004 · Cited by 576
Passive and Active Drug Targeting: Drug Delivery to Tumors as an Example
Torchilin, V. P. (2010) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-00477-3_1 · Cited by 573
Targeted drug delivery by thermally responsive polymers
Chilkoti, A., Dreher, M. R., Meyer, D. E., & Raucher, D. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00041-8 · Cited by 573
A PEGylated dendritic nanoparticulate carrier of fluorouracil
Bhadra, D., Bhadra, S., Jain, S., & Jain, N. K. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00132-7 · Cited by 544
Delivery of Therapeutic Proteins
Pisal, D. S., Kosloski, M. P., & Balu-Iyer, S. V. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22054 · Cited by 532
Cheng, Y., Zhao, L., Li, Y., & Xu, T. (2011) · Chemical Society Reviews · doi:10.1039/c0cs00097c · Cited by 515
PEG conjugates in clinical development or use as anticancer agents: An overview
Pasut, G., & Veronese, F. M. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.02.010 · Cited by 457
Dendrimers as Drug Carriers: Applications in Different Routes of Drug Administration
Cheng, Y., Xu, Z., Ma, M., & Xu, T. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21079 · Cited by 452
Receptor-targeted nanocarriers for therapeutic delivery to cancer
Yu, B., Tai, H. C., Xue, W., Lee, L. J., & Lee, R. J. (2010) · Molecular Membrane Biology · doi:10.3109/09687688.2010.521200 · Cited by 423
Wang, Y.-S., Youngster, S., Grace, M., Bausch, J., Bordens, R., & Wyss, D. F. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00027-3 · Cited by 420
Yin, X., Hoffman, A. S., & Stayton, P. S. (2006) · Biomacromolecules · doi:10.1021/bm0507812 · Cited by 416
Poly(amidoamine) Dendrimer-Based Multifunctional Engineered Nanodevice for Cancer Therapy
Majoros, I. J., Thomas, T. P., Mehta, C. B., & Baker, J. R. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0401863 · Cited by 395
Temperature Triggered Self-Assembly of Polypeptides into Multivalent Spherical Micelles
Dreher, M. R., Simnick, A. J., Fischer, K., Smith, R. J., Patel, A., Schmidt, M., & Chilkoti, A. (2008) · Journal of the American Chemical Society · doi:10.1021/ja0764862 · Cited by 377
YORK, A., KIRKLAND, S., & MCCORMICK, C. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.02.006 · Cited by 349
Dendrimers and supramolecular chemistry
Fréchet, J. M. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082013899 · Cited by 341
Ke, W., Shao, K., Huang, R., Han, L., Liu, Y., Li, J., Kuang, Y., Ye, L., Lou, J., & Jiang, C. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.08.049 · Cited by 337
Multifunctional Micellar Nanomedicine for Cancer Therapy
Blanco, E., Kessinger, C. W., Sumer, B. D., & Gao, J. (2009) · Experimental Biology and Medicine · doi:10.3181/0808-mr-250 · Cited by 332
Pegaspargase: a review of clinical studies
Graham, M. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00110-8 · Cited by 322
Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery
Soga, O., van Nostrum, C. F., Fens, M., Rijcken, C. J. F., Schiffelers, R. M., Storm, G., & Hennink, W. E. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.12.009 · Cited by 319
Polymer conjugates with anticancer activity
Putnam, D., & Kopeček, J. (1995) · Advances in Polymer Science · doi:10.1007/3540587888_14 · Cited by 315
Transepithelial transport and toxicity of PAMAM dendrimers: Implications for oral drug delivery
Sadekar, S., & Ghandehari, H. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.09.010 · Cited by 311
Self-citationGrowing Applications of “Click Chemistry” for Bioconjugation in Contemporary Biomedical Research
Nwe, K., & Brechbiel, M. W. (2009) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2008.0626 · Cited by 309
Seymour (2009) · International Journal of Oncology · doi:10.3892/ijo_00000293 · Cited by 304
PEGylated Poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors
He, H., Li, Y., Jia, X.-R., Du, J., Ying, X., Lu, W.-L., Lou, J.-N., & Wei, Y. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.09.002 · Cited by 303
van Dijk, M., Rijkers, D. T. S., Liskamp, R. M. J., van Nostrum, C. F., & Hennink, W. E. (2009) · Bioconjugate Chemistry · doi:10.1021/bc900087a · Cited by 300
Preparation of micelle-forming polymer-drug conjugates
Yokoyama, M., Kwon, G. S., Okano, T., Sakurai, Y., Seto, T., & Kataoka, K. (1992) · Bioconjugate Chemistry · doi:10.1021/bc00016a007 · Cited by 294
Polysaccharide‐modified synthetic polymeric biomaterials
Baldwin, A. D., & Kiick, K. L. (2010) · Peptide Science · doi:10.1002/bip.21334 · Cited by 287
Meerum Terwogt, J. M., ten Bokkel Huinink, W. W., Schellens, J. H., Schot, M., Mandjes, I. A., Zurlo, M. G., Rocchetti, M., Rosing, H., Koopman, F. J., & Beijnen, J. H. (2001) · Anti-Cancer Drugs · doi:10.1097/00001813-200104000-00003 · Cited by 279
Polyethylene glycol–superoxide dismutase, a conjugate in search of exploitation
Veronese, F. M., Caliceti, P., Schiavon, O., & Sergi, M. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00029-7 · Cited by 273
Targeting and Inhibition of Cell Growth by an Engineered Dendritic Nanodevice
Thomas, T. P., Majoros, I. J., Kotlyar, A., Kukowska-Latallo, J. F., Bielinska, A., Myc, A., & Baker, J. R. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040187v · Cited by 269
Water-Soluble Block Polycations as Carriers for Oligonucleotide Delivery
Kabanov, A. V., Vinogradov, S. V., Suzdaltseva, Y. G., & Alakhov, V. Y. (1995) · Bioconjugate Chemistry · doi:10.1021/bc00036a001 · Cited by 255
Development of HPMA copolymer–anticancer conjugates: Clinical experience and lessons learnt
Duncan, R. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.05.007 · Cited by 252
PEGylated polymers for medicine: from conjugation to self-assembled systems
Joralemon, M. J., McRae, S., & Emrick, T. (2010) · Chemical Communications · doi:10.1039/b920570p · Cited by 251
Introduction and overview of peptide and protein pegylation
Veronese, F. M., & Harris, J. M. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00020-0 · Cited by 243
Lammers, T., Subr, V., Ulbrich, K., Peschke, P., Huber, P. E., Hennink, W. E., & Storm, G. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.02.040 · Cited by 240
Wiwattanapatapee, R., Carreño-Gómez, B., Malik, N., & Duncan, R. (2000) · Pharmaceutical Research · doi:10.1023/a:1007587523543 · Cited by 234
Duncan, R., & Vicent, M. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.12.005 · Cited by 231
Khandare, J. J., Jayant, S., Singh, A., Chandna, P., Wang, Y., Vorsa, N., & Minko, T. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060240p · Cited by 226
Sun, H., Meng, F., Dias, A. A., Hendriks, M., Feijén, J., & Zhong, Z. (2011) · Biomacromolecules · doi:10.1021/bm200043u · Cited by 225
Drug delivery to solid tumors by elastin-like polypeptides
McDaniel, J. R., Callahan, D. J., & Chilkoti, A. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.05.004 · Cited by 217
Levy, Y., Hershfield, M. S., Fernandez-Mejia, C., Polmar, S. H., Scudiery, D., Berger, M., & Sorensen, R. U. (1988) · The Journal of Pediatrics · doi:10.1016/s0022-3476(88)80271-3 · Cited by 215
Rademaker-Lakhai, J. M., Terret, C., Howell, S. B., Baud, C., de Boer, R. F., Pluim, D., Beijnen, J. H., Schellens, J. H. M., & Droz, J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0315 · Cited by 214
Targeted Drugs and Nanomedicine: Present and Future
Debbage, P. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209787002870 · Cited by 213
Micelles based on HPMA copolymers☆
Talelli, M., Rijcken, C. J. F., van Nostrum, C. F., Storm, G., & Hennink, W. E. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.029 · Cited by 211
Elastomeric proteins: biological roles, structures and mechanisms
Tatham, A. S., & Shewry, P. R. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01670-4 · Cited by 209
HPMA copolymers with pH-controlled release of doxorubicin
Ulbrich, K., Etrych, T., Chytil, P., Jelínková, M., & Říhová, B. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00348-6 · Cited by 203
Polymeric drug delivery systems for localized cancer chemotherapy
Souza, R. D., Zahedi, P., Allen, C. J., & Piquette‐Miller, M. (2010) · Drug Delivery · doi:10.3109/10717541003762854 · Cited by 203
Dendrimers as therapeutic agents: a systematic review
Gajbhiye, V., Palanirajan, V. K., Tekade, R. K., & Jain, N. K. (2009) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp/61.08.0002 · Cited by 202
Polyvinyl Pyrrolidone as a Plasma Expander: Studies on Its Excretion, Distribution and Metabolism
Ravin, H. A., Seligman, A. M., & Fine, J. (1952) · New England Journal of Medicine · doi:10.1056/nejm195212112472403 · Cited by 196
The use of PVP as a polymeric carrier to improve the plasma half-life of drugs
Kaneda, Y., Tsutsumi, Y., Yoshioka, Y., Kamada, H., Yamamoto, Y., Kodaira, H., Tsunoda, S.-I., Okamoto, T., Mukai, Y., Shibata, H., et al. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2003.10.003 · Cited by 189
Novel Prodrugs of SN38 Using Multiarm Poly(ethylene glycol) Linkers
Zhao, H., Rubio, B., Sapra, P., Wu, D., Reddy, P., Sai, P., Martinez, A., Gao, Y., Lozanguiez, Y., Longley, C., et al. (2008) · Bioconjugate Chemistry · doi:10.1021/bc700333s · Cited by 188
Preclinical evaluation of polymer-bound doxorubicin
Duncan, R., Seymour, L. W., O'Hare, K. B., Flanagan, P. A., Wedge, S. R., Hume, I. C., Ulbrich, K., Strohalm, J., Šubr, V., Spreafico, F., et al. (1992) · Journal of Controlled Release · doi:10.1016/0168-3659(92)90088-9 · Cited by 187
Mikhail, A. S., & Allen, C. J. (2010) · Biomacromolecules · doi:10.1021/bm100073s · Cited by 181
Julyan, P. J. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00124-2 · Cited by 180
Etrych, T., Kovář, L., Strohalm, J., Chytil, P., Říhová, B., & Ulbrich, K. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.015 · Cited by 176
Trabbic‐Carlson, K., Liu, L., Kim, B., & Chilkoti, A. (2004) · Protein Science · doi:10.1110/ps.04931604 · Cited by 173
Mechanistic studies of in vitro cytotoxicity of poly(amidoamine) dendrimers in mammalian cells
Mukherjee, S. P., Lyng, F. M., Garcia, A., Davoren, M., & Byrne, H. J. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.08.016 · Cited by 172
Sapra, P., Zhao, H., Mehlig, M., Malaby, J., Kraft, P., Longley, C., Greenberger, L. M., & Horak, I. D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4456 · Cited by 168
Size and surface charge significantly influence the toxicity of silica and dendritic nanoparticles
Greish, K. F., Thiagarajan, G., Gustafson, H. H., Price, R., Bauer, H., Hubbard, D., Burckle, A. J., Sadekar, S., Tian, Y., Anwar, A., et al. (2011) · Nanotoxicology · doi:10.3109/17435390.2011.604442 · Cited by 166
Self-citationSeymour, L. W., Ulbrich, K., Steyger, P. S., Brereton, M., Šubr, V., Strohalm, J., & Duncan, R. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.363 · Cited by 164
20-O-Acylcamptothecin Derivatives: Evidence for Lactone Stabilization
Zhao, H., Lee, C., Sai, P., Choe, Y. H., Boro, M., Pendri, A., Guan, S., & Greenwald, R. B. (2000) · The Journal of Organic Chemistry · doi:10.1021/jo000221n · Cited by 162
Jia, Z., Wong, L., Davis, T. P., & Bulmus, V. (2008) · Biomacromolecules · doi:10.1021/bm800657e · Cited by 160
Wang, D., Miller, S. C., Liu, X., Anderson, B., Wang, X., & Goldring, S. R. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2106 · Cited by 159
Self-immolative linkers in polymeric delivery systems
Blencowe, C. A., Russell, A. T., Greco, F., Hayes, W., & Thornthwaite, D. W. (2010) · Polymer Chemistry · doi:10.1039/c0py00324g · Cited by 159
Controlled biodegradability of polymers — a key to drug delivery systems
Kopec̆ek, J. (1984) · Biomaterials · doi:10.1016/0142-9612(84)90062-0 · Cited by 155
Anti-cancer PEG-enzymes: 30 years old, but still a current approach
Pasut, G., Sergi, M., & Veronese, F. M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.018 · Cited by 152
Thermal Cycling Enhances the Accumulation of a Temperature-Sensitive Biopolymer in Solid Tumors
Dreher, M. R., Liu, W., Michelich, C. R., Dewhirst, M. W., & Chilkoti, A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4444 · Cited by 150
Metselaar, J. M., de Bruin, P., de Boer, L. W. T., de Vringer, T., Snel, C. J., Oussoren, C., Wauben, M. H. M., Crommelin, D. J. A., Storm, G., & Hennink, W. E. (2003) · Bioconjugate Chemistry · doi:10.1021/bc0340363 · Cited by 149
Targeting tumor angiogenic vasculature using polymer–RGD conjugates
Mitra, A., Mulholland, J., Nan, A., McNeill, E., Ghandehari, H., & Line, B. R. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.09.023 · Cited by 148
Self-citationZhou, L., Cheng, R., Tao, H., Ma, S., Guo, W., Meng, F., Liu, H., Liu, Z., & Zhong, Z. (2011) · Biomacromolecules · doi:10.1021/bm101340u · Cited by 146
Luo, K., Yang, J., Kopečková, P., & Kopec̆ek, J. (2011) · Macromolecules · doi:10.1021/ma102574e · Cited by 140
Rejmanová, P., Kopec̆ek, J., Duncan, R., & Lloyd, J. B. (1985) · Biomaterials · doi:10.1016/0142-9612(85)90037-7 · Cited by 138
Dendrimer-Based Contrast Agents for Molecular Imaging
Longmire, M. R., Choyke, P. L., & Kobayashi, H. (2008) · Current Topics in Medicinal Chemistry · doi:10.2174/156802608785849021 · Cited by 138
Rowinsky, E. K., Rizzo, J. D., Ochoa, L., Takimoto, C. H. M., Forouzesh, B., Schwartz, G. H., Hammond, L. A., Patnaik, A., Kwiatek, J., Goetz, A. D., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.143 · Cited by 132
Chytil, P., Etrych, T., Koňák, Č., Šírová, M., Mrkvan, T., Bouček, J., Řı́hová, B., & Ulbrich, K. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.01.007 · Cited by 126
Chipman, S. D., Oldham, F. B., Pezzoni, G., & Singer, J. W. (2006) · International Journal of Nanomedicine · doi:10.2147/nano.2006.1.4.375 · Cited by 125
Lammers, T. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.028 · Cited by 125
O'Brien, M. E. R., Socinski, M. A., Popovich, A. Y., Bondarenko, I., Tomova, A., ̆ı, B. T. B., Hotko, Y., Ganul, V. L., Kostinsky, I. Y., Eisenfeld, A. J., et al. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31817c6b68 · Cited by 125
Menjoge, A. R., Rinderknecht, A. L., Navath, R. S., Faridnia, M., Kim, C. J., Romero, R. J., Miller, R. K., & Kannan, R. M. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.023 · Cited by 124
HPMA Copolymer Conjugates of Paclitaxel and Docetaxel with pH-Controlled Drug Release
Etrych, T., Šírová, M., Starovoytová, L., Říhová, B., & Ulbrich, K. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100119f · Cited by 123
Temperature sensitive peptides: Engineering hyperthermia-directed therapeutics
MacKay, J. A., & Chilkoti, A. (2008) · International Journal of Hyperthermia · doi:10.1080/02656730802149570 · Cited by 122
Liu, X. M., Quan, L., Tian, J., Alnouti, Y., Fu, K., Thiele, G. M., & Wang, D. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9683-3 · Cited by 118
Campone, M., Rademaker-Lakhai, J. M., Bennouna, J., Howell, S. B., Nowotnik, D. P., Beijnen, J. H., & Schellens, J. H. M. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0397-0 · Cited by 115
Yang, J., Luo, K., Pan, H., Kopečková, P., & Kopec̆ek, J. (2010) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2010.10.005 · Cited by 114
Polymeric Carriers for Gene Delivery: Chitosan and Poly(amidoamine) Dendrimers
Xu, Q., Wang, C., & Pack, D. W. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791920469 · Cited by 110
Design, Synthesis, and Biological Evaluation of a Robust, Biodegradable Dendrimer
van der Poll, D. G., Ferguson, H. M., Floyd, W. C., Guillaudeu, S. J., Jerger, K., Szoka, F. C., & Fréchet, J. M. J. (2010) · Bioconjugate Chemistry · doi:10.1021/bc900553n · Cited by 103
Lele, B. S., & Leroux, J. (2002) · Macromolecules · doi:10.1021/ma020433h · Cited by 102
Šebestík, J., Niederhafner, P., & Ježek, J. (2010) · Amino Acids · doi:10.1007/s00726-010-0707-z · Cited by 102
Wang, T., Petrenko, V. A., & Torchilin, V. P. (2010) · Molecular Pharmaceutics · doi:10.1021/mp1001125 · Cited by 100
Yurkovetskiy, A., & Fram, R. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.01.007 · Cited by 100
Biodegradable star HPMA polymer conjugates of doxorubicin for passive tumor targeting
Etrych, T., Strohalm, J., Chytil, P., Černoch, P., Starovoytová, L., Pechar, M., & Ulbrich, K. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.03.001 · Cited by 100
Miller, K., Eldar‐Boock, A., Polyak, D., Segal, E., Benayoun, L., Shaked, Y., & Satchi‐Fainaro, R. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200083n · Cited by 100
HPMA-based polymer conjugates with drug combination
Krakovičová, H., Etrych, T., & Ulbrich, K. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.03.011 · Cited by 99
HPMA copolymer–cyclic RGD conjugates for tumor targeting☆☆☆
Pike, D. B., & Ghandehari, H. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.027 · Cited by 99
Self-citationConjugates of doxorubicin with graft HPMA copolymers for passive tumor targeting
Etrych, T., Chytil, P., Mrkvan, T., Šírová, M., Říhová, B., & Ulbrich, K. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.04.017 · Cited by 98
Poly(ethylene glycol) Multiblock Copolymer as a Carrier of Anti-Cancer Drug Doxorubicin
Pechar, M., Ulbrich, K., Šubr, V., Seymour, L. W., & Schacht, E. H. (2000) · Bioconjugate Chemistry · doi:10.1021/bc990092l · Cited by 97
In vivo toxicity of poly(propyleneimine) dendrimers
Ziemba, B., Janaszewska, A., Ciepluch, K., Krotewicz, M., Fogel, W. A., Appelhans, D., Voit, B. I., Bryszewska, M. J., & Klajnert‐Maculewicz, B. (2011) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.33196 · Cited by 97
Neradovic, D., van Steenbergen, M. J., Vansteelant, L., Meijer, Y. J., van Nostrum, C. F., & Hennink, W. E. (2003) · Macromolecules · doi:10.1021/ma034381n · Cited by 95
Kamada, H., Tsutsumi, Y. M., Yamamoto, Y., Kihira, T., Kaneda, Y., Mu, Y., Kodaira, H., Tsunoda, S., Nakagawa, S., & Mayumi, T. (2000) · PubMed · Cited by 93
Ljubimova, J. Y., Fujita, M., Ljubimov, A. V., Torchilin, V. P., Black, K. L., & Holler, E. (2008) · Nanomedicine · doi:10.2217/17435889.3.2.247 · Cited by 88
PEGylated Interferon-α2b: A Branched 40K Polyethylene Glycol Derivative
Ramón, J., Saez, V. M., Báez, R., Aldana, R., & Hardy, E. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-5278-4 · Cited by 86
A 5-fluorouracil-loaded pH-responsive dendrimer nanocarrier for tumor targeting
Jin, Y., Ren, X., Wang, W., Ke, L., Ning, E., Du, L., & Bradshaw, J. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.08.053 · Cited by 83
Methotrexate delivery via folate targeted dendrimer‐based nanotherapeutic platform
Majoros, I., WILLIAMS, C. R., Becker, A., & Baker, J. R. (2009) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.37 · Cited by 83
Thomson, A. H., Vasey, P. A., Murray, L. S., Cassidy, J., Fraier, D., Frigerio, E., & Twelves, C. J. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690657 · Cited by 81
Design, Synthesis and Potent Pharmaceutical Applications of Glycodendrimers:A Mini Review
Li, Y., Cheng, Y., & Xu, T. (2007) · Current Drug Discovery Technologies · doi:10.2174/157016307783220503 · Cited by 79
Pegylation for improving the effectiveness of therapeutic biomolecules
Pasut, G., & Veronese, F. M. (2009) · Drugs of today · doi:10.1358/dot.2009.45.9.1416421 · Cited by 78
Solubility and in vitro transdermal diffusion of riboflavin assisted by PAMAM dendrimers
Filipowicz-Rachwał, A., & Wołowiec, S. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.01.033 · Cited by 78
Coiled-coil based drug-free macromolecular therapeutics: In vivo efficacy
Wu, K., Yang, J., Liu, J., & Kopec̆ek, J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.002 · Cited by 77
Hybrid Polymer Therapeutics Incorporating Bioresponsive, Coiled Coil Peptide Linkers
Apostolovic, B., Deacon, S. P. E., Duncan, R., & Klok, H. (2010) · Biomacromolecules · doi:10.1021/bm901313c · Cited by 77
Preclinical toxicology of a novel polymeric antitumour agent: HPMA copolymer-doxorubicin (PK1)
Duncan, R., Coatsworth, J. K., & Burtles, S. S. (1998) · Human & Experimental Toxicology · doi:10.1177/096032719801700204 · Cited by 76
van (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s13482 · Cited by 75
Raghupathi, K. R., Azagarsamy, M. A., & Thayumanavan, S. (2011) · Chemistry - A European Journal · doi:10.1002/chem.201101066 · Cited by 68
Carboxyl-Terminated PAMAM-SN38 Conjugates: Synthesis, Characterization, and in Vitro Evaluation
Vijayalakshmi, N., Ray, A., Malugin, A., & Ghandehari, H. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100094z · Cited by 66
Self-citationGoldberg, D. S., Ghandehari, H., & Swaan, P. W. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0153-3 · Cited by 65
Self-citationMalugin, A., Kopečková, P., & Kopeček, J. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.08.016 · Cited by 64
Reconstitutable charged polymeric (PLGA)2-b-PEI micelles for gene therapeutics delivery
Mishra, D., Kang, H. C., & Bae, Y. H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.077 · Cited by 63
Paclitaxel poliglumex for ovarian cancer
Galic, V., Wright, J. D., Lewin, S. N., & Herzog, T. J. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.576666 · Cited by 60
Ray, A., Larson, N., Pike, D. B., Grüner, M., Naik, S., Bauer, H., Malugin, A., Greish, K. F., & Ghandehari, H. (2011) · Molecular Pharmaceutics · doi:10.1021/mp100402n · Cited by 60
Self-citationChandran, S. S., Nan, A., Rosen, D. M., Ghandehari, H., & Denmeade, S. R. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0392 · Cited by 59
Self-citationDegradation and Degradation-Induced Re-Assembly of PVP-PCL Micelles
Hu, Y., Jiang, Z., Chen, R., Wu, W., & Jiang, X. (2010) · Biomacromolecules · doi:10.1021/bm901211r · Cited by 57
Polymer Micelles with Hydrazone-Ester Dual Linkers for Tunable Release of Dexamethasone
Howard, M. D., Ponta, A., Eckman, A. M., Jay, M., & Bae, Y. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0470-1 · Cited by 57
Dendrimers as Novel Systems for Delivery of Neuropharmaceuticals to the Brain
Beg, S., Samad, A., Alam, M. I., & Nazish, I. (2011) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152711796235023 · Cited by 57
Thiagarajan, G., Ray, A., Malugin, A., & Ghandehari, H. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0179-6 · Cited by 51
Self-citationŠubr, V., Kopec̆ek, J., Pohl, J., Baudyš, M., & Kostka, V. (1988) · Journal of Controlled Release · doi:10.1016/0168-3659(88)90039-9 · Cited by 51
Sabbatini, P. J., Sill, M. W., O’Malley, D. M., et al. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.07.049 · Cited by 49
Borgman, M. P., Aras, Ö., Geyser-Stoops, S., Sausville, E. A., & Ghandehari, H. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900134c · Cited by 49
Self-citationSynthesis and characterization of HPMA copolymer–aminopropylgeldanamycin conjugates
Kasuya, Y., Lu, Z., Kopečková, P., Minko, T., Tabibi, S. E., & Kopec̆ek, J. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00318-2 · Cited by 48
Yasukawa, T., Kimura, H., Tabata, Y., Miyamoto, H., Honda, Y., Ikada, Y., & Ogura, Y. (1999) · PubMed · Cited by 47
Lee, J. Y., Bae, K. H., Kim, J. S., Nam, Y. S., & Park, T. G. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.063 · Cited by 45
Design and evaluation of micellar nanocarriers for 17-allyamino-17-demethoxygeldanamycin (17-AAG)
Chandran, T., Katragadda, U., Teng, Q., & Tan, C. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.03.056 · Cited by 45
Polymer−Drug Conjugates for Combination Anticancer Therapy: Investigating the Mechanism of Action
Pasut, G., Greco, F., Mero, A., Mendichi, R., Fante, C., Green, R. J., & Veronese, F. M. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900804m · Cited by 44
Targetable HPMA Copolymer–Aminohexylgeldanamycin Conjugates for Prostate Cancer Therapy
Borgman, M. P., Ray, A., Kolhatkar, R. B., Sausville, E. A., Burger, A. M., & Ghandehari, H. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9851-0 · Cited by 44
Self-citationCao, W., Zhou, J., Wang, Y., & Zhu, L. J. (2010) · Biomacromolecules · doi:10.1021/bm101154r · Cited by 42
Greish, K. F., Ray, A., Bauer, H., Larson, N., Malugin, A., Pike, D. B., Haider, M. A., & Ghandehari, H. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.12.015 · Cited by 40
Self-citationKemp, J. D., Cardillo, T. M., Stewart, B. C., Kehrberg, E., Weiner, G. J., Hedlund, B. E., & Naumann, P. W. (1995) · PubMed · Cited by 40
The use of reversible addition fragmentation chain transfer polymerization for drug delivery systems
Gregory, A. M., & Stenzel, M. H. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.548381 · Cited by 39
Krimmer, S. G., Pan, H., Liu, J., Yang, J., & Kopec̆ek, J. (2011) · Macromolecular Bioscience · doi:10.1002/mabi.201100019 · Cited by 38
Larson, N., Ray, A., Malugin, A., Pike, D. B., & Ghandehari, H. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0267-7 · Cited by 36
Self-citationZhou, P., Li, Z., & Chau, Y. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.07.014 · Cited by 27
Nanomedicines in the treatment of acromegaly: focus on pegvisomant
Roelfsema, F., Biermasz, N. R., Pereira, A. M., & Romijn, J. A. (2006) · International Journal of Nanomedicine · doi:10.2147/nano.2006.1.4.385 · Cited by 23
Peptide−Poly( l -lysine citramide) Conjugates and their In Vitro Anti-HIV Behavior
Couffin, A., Aubertin, A.-M., Boustta, M., Schmidt, S., Fehrentz, J., Martínez, J., & Vert, M. (2009) · Biomacromolecules · doi:10.1021/bm801376v · Cited by 23
HPMA Copolymer-1,5-Diazaanthraquinone Conjugates as Novel Anticancer Therapeutics
Vicent, M. J., Manzanaro, S., de la Fuente, J. Á., & Duncan, R. (2004) · Journal of drug targeting · doi:10.1080/10611860400011901 · Cited by 23
Modified Doxorubicin for Improved Encapsulation in PVA Polymeric Micelles
Orienti, I., Zuccari, G., Fini, A., Rabasco, A. M., Montaldo, P. G., Raffaghello, L., & Carosio, R. (2004) · Drug Delivery · doi:10.1080/10717540590889574 · Cited by 19
Macromolecular nanotheranostics for multimodal anticancer therapy
Veld, R. H. I. '., Storm, G., Hennink, W. E., Kiessling, F. M., & Lammers, T. (2011) · Nanoscale · doi:10.1039/c1nr10733j · Cited by 13
Cited by
Polyphenol‐Containing Nanoparticles: Synthesis, Properties, and Therapeutic Delivery
Guo, Y., Sun, Q., Wu, F., Dai, Y., & Chen, X. (2021) · Advanced Materials · doi:10.1002/adma.202007356 · Cited by 650
Preparation and application of pH-responsive drug delivery systems
Ding, H., Tan, P., Fu, S., Tian, X., Zhang, H., Ma, X., Gu, Z., & Luo, K. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.05.056 · Cited by 645
Recent advances of controlled drug delivery using microfluidic platforms
Sanjay, S. T., Zhou, W., Dou, M., Tavakoli, H., Ma, L., Xu, F., & Li, X. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.09.013 · Cited by 365
Polymeric nanostructured materials for biomedical applications
Tang, Z., He, C., Tian, H., Ding, J., Hsiao, B. S., Chu, B., & Chen, X. (2016) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2016.05.005 · Cited by 363
PLGA-based nanomedicines manufacturing: Technologies overview and challenges in industrial scale-up
Operti, M. C., Bernhardt, A., Grimm, S., Engel, A., Figdor, C. G., & Tagit, O. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120807 · Cited by 302
Metadata
- Authors
- Larson, N., & Ghandehari, H.
- Venue
- Chemistry of Materials
- Publisher
- American Chemical Society (ACS)
- Published
- 2012-01-04
- Volume
- 24
- Issue
- 5
- Pages
- 840-853
- ISSN
- 0897-4756 (ISSN-L)
- 1520-5002
- OpenAlex
- W2072198924
- Cited by
- 580
- References
- 187
- FWCI
- 15.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.